Preparations for Mass Vaccination
We are pleased to confirm that the Pfizer Agreement for 20 million doses of vaccines has been signed and that payment processes are underway to close the deal in the next few days. With the Johnson and Johnson Agreement also fully concluded, this sets the stage for a significant and rapid expansion of our vaccination programme.
In addition we can also confirm that the final tranche of 200 000 Johnson and Johnson doses for the Sisonke Protocol is expected to arrive on 10 April 2021. These doses will take us to the last mile of the Sisonke Protocol, which is set to become one of the most seminal studies in the history of the pandemic.
Similarly, we will also embark on an implementation study with a limited number of Pfizer doses used amongst health care workers- this will be yet another valuable contribution to the science of mass vaccination.
In preparation for the mass vaccination campaign, we have undertaken a deep study of the Sisonke Protocol to draw lessons from the programme and enhance the efficiency of future operations.
We have also continued to engage stakeholders across all sectors to sensitise ourselves to the needs of various communities.